From developing new therapies that treat and prevent disease to helping people in need, we’re committed to improving health and well-being around the world. Our vision is to make a difference in the lives of people globally through our innovative medicines, vaccines, biologic therapies, consumer care and animal health products. We aspire to be the best healthcare company in the world and are dedicated to providing leading innovations and solutions for tomorrow.
Transpharmation Ltd. is a preclinical contract research organization led by scientists. Established in 2010 and building on the international reputation and CNS drug discovery expertise of the founders, Transpharmation is recognized by drug developers worldwide for researching and delivering life-changing medicines. Clients benefit from decades of experience in cross-species and cross-therapeutic area translational biology throughout multiple neuroscience preclinical services, including neurodegeneration, neuroinflammation, cognition, anxiety/mood disorders (including treatment-resistant depression and schizophrenia), pain, EEG and epilepsy together with a biomarker platform and human tissue capabilities. At Transpharmation, science will always remain our passion driven by our desire to make a difference.